“Breaking News: LIXTE Biotechnology Announces $1.05M Registered Direct Offering Under Nasdaq Rules!”

Exciting News from LIXTE Biotechnology! A New Chapter for LIXTE It’s always thrilling to hear about new developments in the pharmaceutical industry, and today is no exception. LIXTE Biotechnology Holdings, Inc. has just announced that it will be entering into definitive agreements for the purchase and sale of shares of its common stock in a…

Read More

US Sec Secrets: Grayscale’s XRP ETF Decision Delayed – Peek into the Time Capsule for 2025!

The Gray Scale XRP Exchange-Traded Fund: A Halt in the Track towards Mainstream Adoption In a recent turn of events, the United States Securities and Exchange Commission (SEC) has postponed its decision on Grayscale Investments’ application for an XRP exchange-traded fund (ETF). This announcement was made in an SEC notice published on March 10, 2023….

Read More

“Qualcomm and ARM: A Resolution to Breach Claims and the Future of Their License Agreement”

Qualcomm’s License Agreement with Arm Holdings Saved What Happened? Qualcomm’s Chief Executive Officer Cristiano Amon announced on Wednesday that Arm Holdings has decided to withdraw their threat to terminate Qualcomm’s license agreement with the technology provider. This comes as a relief for both companies and the tech industry as a whole. Why is this Important?…

Read More